Tocilizumab 162mg/0.9ml solution for injection pre-filled disposable devices
NHS hospitals in England used £64,092,349 of indicative cost of Tocilizumab 162mg/0.9ml solution for injection pre-filled disposable devices in the 12 months to July 2026, about 0.2% of all hospital medicines spend. That is up 21.5% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Tocilizumab 162mg/0.9ml solution for injection pre-filled disposable devices: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Tocilizumab 162mg/0.9ml solution for injection pre-filled disposable devices most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £1,820,533 |
| Royal Free London Nhs Foundation Trust | £1,716,437 |
| Manchester University Nhs Ft | £1,650,693 |
| Leeds Teaching Hpls Nhs Trust | £1,510,300 |
| Aintree University Hospital Nhs Ft | £1,430,859 |
| Portsmouth Hospitals Nhs Trust | £1,351,874 |
| Sheffield Teaching Hospitals Nhs Trust | £1,286,358 |
| Oxford University Hospitals Nhs Ft | £1,246,637 |
| University Hpls Of Leicester Nhs Trust | £1,214,678 |
| Western Sussex Hospitals Nhs Found Trust | £1,170,163 |
The primary-care picture
Tocilizumab is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Tocilizumab medicine page.